Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Foods (Basel, Switzerland)
|
July 2, 2021
In-House Validation of an SPE-GC-FID Method for the Detection of Free and Esterified Hydroxylated Minor Compounds in Virgin Olive Oils
Enrico Valli, Andrea Milani, Ana Srbinovska, et al.
ESMO Open
|
August 30, 2017
Switching from standard to dose-dense chemotherapy in front-line treatment of advanced ovarian cancer: a retrospective study of feasibility and efficacy
Andrea Milani, Rebecca Kristeleit, Mary McCormack, et al.
The Breast Journal
|
April 2, 2019
Trastuzumab-related cardiotoxicity in patients with nonlimiting cardiac comorbidity
Rossella Martinello, Paolo Becco, Patrizia Vici, et al.
Breast Cancer Research and Treatment
|
December 15, 2010
HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib
Giorgio Valabrega, Sonia Capellero, Giuliana Cavalloni, et al.
Oncotargets and Therapy
|
May 23, 2019
Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future?
Marina Elena Cazzaniga, Laura Biganzoli, Laura Cortesi, et al.
Tumori
|
January 7, 2023
Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society
Andrea Milani, Valentina Tuninetti, Sandro Pignata, et al.
Cancer Medicine
|
July 22, 2018
Self-evaluation of duration of adjuvant chemotherapy side effects in breast cancer patients: A prospective study
Danilo Galizia, Andrea Milani, Elena Geuna, et al.
Molecular Oncology
|
June 26, 2014
The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition
Elena Ardini, Roberta Bosotti, Andrea Lombardi Borgia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2021
Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET)
Claudio Vernieri, Federico Nichetti, Luca Lalli, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Foods (Basel, Switzerland)
|
July 2, 2021
In-House Validation of an SPE-GC-FID Method for the Detection of Free and Esterified Hydroxylated Minor Compounds in Virgin Olive Oils
Enrico Valli, Andrea Milani, Ana Srbinovska, et al.
ESMO Open
|
August 30, 2017
Switching from standard to dose-dense chemotherapy in front-line treatment of advanced ovarian cancer: a retrospective study of feasibility and efficacy
Andrea Milani, Rebecca Kristeleit, Mary McCormack, et al.
The Breast Journal
|
April 2, 2019
Trastuzumab-related cardiotoxicity in patients with nonlimiting cardiac comorbidity
Rossella Martinello, Paolo Becco, Patrizia Vici, et al.
Breast Cancer Research and Treatment
|
December 15, 2010
HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib
Giorgio Valabrega, Sonia Capellero, Giuliana Cavalloni, et al.
Oncotargets and Therapy
|
May 23, 2019
Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future?
Marina Elena Cazzaniga, Laura Biganzoli, Laura Cortesi, et al.
Tumori
|
January 7, 2023
Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society
Andrea Milani, Valentina Tuninetti, Sandro Pignata, et al.
Cancer Medicine
|
July 22, 2018
Self-evaluation of duration of adjuvant chemotherapy side effects in breast cancer patients: A prospective study
Danilo Galizia, Andrea Milani, Elena Geuna, et al.
Molecular Oncology
|
June 26, 2014
The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition
Elena Ardini, Roberta Bosotti, Andrea Lombardi Borgia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2021
Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET)
Claudio Vernieri, Federico Nichetti, Luca Lalli, et al.
Page
of 4